Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study-Reference-Cited by-同舟云学术

Experience with rituximab in scleroderma: results from a 1-year, proof-of-principle study

Published:2009-11-18 Issue:2 Volume:49 Page:271-280
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Daoussis Dimitrios,Liossis Stamatis-Nick C.,Tsamandas Athanassios C.,Kalogeropoulou Christina,Kazantzi Alexandra,Sirinian Chaido,Karampetsou Maria,Yiannopoulos Georgios,Andonopoulos Andrew P.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/49/2/271/17386681/kep093.pdf

Reference45 articles.

1. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006

2. Effects of 1-year treatment with cyclophosphamide on outcomes at 2 years in scleroderma lung disease;Tashkin;Am J Respir Crit Care Med,2007

3. A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma;Hoyles;Arthritis Rheum,2006

4. Combination of intravenous pulses of cyclophosphamide and methylprednizolone in patients with systemic sclerosis and interstitial lung disease;Yiannopoulos;Rheumatol Int,2007

5. Mycophenolate mofetil as first-line treatment improves clinically evident early scleroderma lung disease;Liossis;Rheumatology,2006

Cited by 336 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 2023 Brazilian Society of Rheumatology guidelines for the treatment of systemic sclerosis;Advances in Rheumatology;2024-07-10

2. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis & Rheumatology;2024-07-08

3. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis Care & Research;2024-07-08

4. Successful long-term systemic sclerosis treatment by high-frequent low-dose B cell-depleting therapy;Journal of Autoimmunity;2024-07

5. Safety and Tolerability of Rituximab in the Treatment of Systemic Sclerosis;Doklady Biochemistry and Biophysics;2024-06-10